Qualcomm Closes Strong Fiscal 2024 with Record Cash Flow and Double-Digit EPS Growth
New $15 Billion Stock Buyback Program Announced Amid Success in Automotive and IoT Markets n a resounding conclusion to fiscal...
Trump’s Re-Election Sparks Stock Movements: Key Winners and Losers for Investors
Tech, Energy, and Industrial Stocks to Watch as Trump’s Policies Shape Market Sentiment With Donald J. Trump re-elected as the...
Super Micro Computer Reports Preliminary Q1 Financials and Concludes Independent Investigation
Company Misses Revenue Guidance but Strengthens Governance After Special Committee Review Super Micro Computer (SMCI), a leading provider of IT...
e.l.f. Beauty Defies Industry Slowdown with Strong Second-Quarter Sales Growth
Affordable Cosmetics Strategy Helps e.l.f. Gain Market Share Amid Weak Demand for Premium Brands e.l.f. Beauty (ELF) is projected to...
Why Investors Should Keep An Eye On Alibaba Holdings For Long-Term Gains
Despite Market Fluctuations, Alibaba’s Strategic Positioning and Growth Potential Make it a Compelling Investment Choice In the realm of Chinese...
Viking Therapeutics’ VK2735 Demonstrates Promising Weight Loss Results in Phase 1 and Phase 2 Trials
Clinical Data from Oral and Subcutaneous Doses Show Effective Weight Loss and Support Potential for Long-Term Dosing Strategies Viking Therapeutics...
Intel’s Q3 2024: Navigating Financial Challenges with Strategic Moves
Restructuring Costs and Growth Initiatives Signal Intel's Path to Recovery Intel Corporation (INTC) released its third-quarter 2024 financial report, highlighting...
Carvana Achieves Record Profitability in Q3 with 34% Retail Growth, Forecasts Strong Q4
With Industry-Leading Adjusted EBITDA Margin and Rising Retail Sales, Carvana Sets a New Standard in Automotive Retail Carvana Co. (CVNA),...
Roku Surpasses $1 Billion in Q3 Revenue, Boosted by Platform and Device Success
Strong Revenue Growth and Enhanced Viewer Engagement Highlight Roku’s Momentum as It Eyes Further Expansion Roku (ROKU) has reported a...
Tharimmune Advances TH104 Clinical Program for Pruritus in PBC With EMA Guidance
Positive EMA Feedback Boosts Momentum for Tharimmune’s Phase 2 Trial in Treating Debilitating Itch Condition in Primary Biliary Cholangitis Tharimmune...
